Vogt Koyanagi Harada disease managed with immunomodulatory therapy within 3 months of disease onset

To study the outcome of high dose corticosteroids with early addition of immunomodulatory therapy (IMT) on Vogt Koyanagi Harada disease (VKH).

Source: American Journal of Ophthalmology - July 28, 2020 Category: Opthalmology Authors: Ei Ei Lin Oo, Soon-Phaik Chee, Kelvin Wong Kin Yan, Hla Myint Htoon Tags: Original Articles Source Type: research